openPR Logo
Press release

GenoFAB Launches Hybrid Plasmid Sequencing Service To Set a New Standard for Reproducibility in Biotechnology

02-24-2025 04:18 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: Brand Push
GenoFAB Launches Hybrid Plasmid Sequencing Service To Set a New

New service enhances plasmid quality control for research and manufacturing.
Image: https://www.globalnewslines.com/uploads/2025/02/fe7ca2654c3c0350e277e71d3a85afcc.jpg

GenoFAB is introducing a whole plasmid sequencing service, a groundbreaking solution designed to enhance reproducibility and quality control in biotechnology research and biomanufacturing. By leveraging both long-read and short-read sequencing technologies, GenoFAB ensures unprecedented base-level accuracy, addressing a critical challenge in the field.

Plasmids are the foundation of many biopharmaceutical, synthetic biology, and gene therapy applications, yet plasmid quality control remains a persistent bottleneck. Errors in plasmid sequences can lead to failed experiments, regulatory setbacks, and compromised product performance. GenoFAB's new service provides researchers and biotech companies with a reliable way to validate and manage plasmid integrity throughout the entire product lifecycle-from early-stage R&D to commercial manufacturing.

Meeting the Growing Need for Plasmid Quality Control

As biomanufacturing scales up and regulatory standards tighten, ensuring the integrity of plasmids has become more critical than ever. Unlike traditional sequencing approaches that can be challenged by complex sequences, GenoFAB's hybrid sequencing method combines the advantages of long-read sequencing for Oxford Nanopore to capture structural variants and short-read sequencing from Illumina to ensure base-level accuracy.

This service builds on recent research results published in ACS Synthetic Biology [https://pubs.acs.org/doi/abs/10.1021/acssynbio.4c00539] and Bioinformatics [https://academic.oup.com/bioinformatics/article/40/5/btae299/7663467], where GenoFAB's team introduced a new bioinformatics pipeline designed to increase the reproducibility and reliability of sequencing workflows. The service is an integral part of GenoFAB's plasmid management platform [https://genofab.com/collections/services] that includes plasmid design, plasmid construction and purification, and the management of private plasmid repositories. These integrated services ensure that plasmids meet the highest standards at every stage of development and manufacturing.

Designed for a Wide Range of Users

GenoFAB's plasmid sequencing service can be tailored to meet the needs of a variety of stakeholders in the life sciences, including:

- Academic scientists who need to control plasmids the integrity of the plasmids they use to test novel scientific hypotheses or groundbreaking applications of machine learning and artificial intelligence.

- Biotech companies who rely on plasmids to develop gene therapies, cell therapies, and engineer cell lines to produce biologic drugs and regenerative medicines.

- Operators of biomanufacturing facilities needing to control the quality of plasmids used to produce recombinant proteins and mRNAs

"We're excited to bring our plasmid sequencing capabilities to the scientific community," said Jean Peccoud, Founder of GenoFAB and Professor at Colorado State University. "For years, the industry has struggled with reproducibility issues. By ensuring plasmid quality at every stage of the research and development process, we can help scientists improve the performance of their products while meeting the most stringent regulatory standards."

A Step Toward Smarter Plasmid Management

GenoFAB's all-inclusive sequencing service eliminates the need for users to prepare sequencing-grade plasmid solutions, reducing the risk of contamination and user error. By combining automated workflows with cutting-edge bioinformatics, the service offers a scalable solution that enables life scientists to focus on discovery rather than troubleshooting plasmid errors.

Looking ahead, GenoFAB is expanding its suite of plasmid management tools with the goal of securing the exchange of critical biological materials in the bioeconomy supply chain.

Learn more about GenoFAB's whole plasmid sequencing services [https://genofab.com/products/whole-plasmid-sequencing].

About GenoFAB

GenoFAB helps life scientists and biotechnology companies accelerate research and product development by delivering the plasmids they need when they need them. The company eliminates the risks of poor plasmid management-unexpected delays, cost overruns, quality control issues, and commercialization roadblocks-so scientists can focus on discovery and companies can focus on their core business. GenoFAB's comprehensive plasmid management services span the entire plasmid lifecycle, from design to distribution and commercialization.
Media Contact
Company Name: GenoFAB, Inc.
Contact Person: Jean Peccoud
Email: Send Email [http://www.universalpressrelease.com/?pr=genofab-launches-hybrid-plasmid-sequencing-service-to-set-a-new-standard-for-reproducibility-in-biotechnology]
Country: United States
Website: https://www.genofab.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GenoFAB Launches Hybrid Plasmid Sequencing Service To Set a New Standard for Reproducibility in Biotechnology here

News-ID: 3883842 • Views:

More Releases from Getnews

Dr JG Ramirez Exposes the Hidden Truth of Human Slavery in Her Powerful Novel Misery's Tale
Dr JG Ramirez Exposes the Hidden Truth of Human Slavery in Her Powerful Novel Mi …
Image: https://www.aionewswire.com/storage/images/ckeditor//julieanna%20pic_1761776037.jpg Clinical Psychologist and mediator Dr. J.G. Ramirez presents Misery's Tale, [https://www.amazon.com/Miserys-Tale-J-G-Ramirez/dp/B0CTZ35L35] a powerful literary work that confronts the stark realities of human trafficking and the silence that surrounds it. Through storytelling and deep psychological insight, Ramirez exposes the unseen struggles of those trapped in cycles of exploitation and neglect. Misery's Tale [https://www.amazon.com/Miserys-Tale-J-G-Ramirez/dp/B0CTZ35L35] invites readers into a world where pain, resilience, and truth intertwine. Each page reveals the complexity of human
Lake Revitalizes Culture and Tourism -
Lake Revitalizes Culture and Tourism - "Changsha in One Minute" Explores the Eco …
Video: https://www.youtube.com/embed/1zdAIVH3z7g By the Xiang River, a sparkling emerald gem shines. The bilingual micro video "Changsha in One Minute" invites you to explore Qianlong Lake in Wangcheng, Changsha, and experience its blend of natural ecology and cultural charm. Covering a water area of 2,480 mu, Qianlong Lake glistens under the sun, home to more than 100 bird species and about 400 kinds of wild plants, with aquatic vegetation covering up to 63%
German Media Group YES Group Enters U.S. Market With Acquisition of Stockstoday.com
German Media Group YES Group Enters U.S. Market With Acquisition of Stockstoday. …
German financial media company expands internationally by acquiring U.S. financial news platform Stockstoday.com, strengthening cross-border coverage of the stock market, stocks, finance, and the global economy. Image: https://www.globalnewslines.com/uploads/2025/08/cdedffec68d7c33845fb04da73df3671.jpg YES Group [https://www.linkedin.com/company/yes-investmedia/], a financial media organization based in Germany, announced it has entered the U.S. market through the acquisition of Stockstoday.com [http://stockstoday.com], a financial news portal that covers the stock market [https://stockstoday.com/], individual stocks, and developments across finance and the global economy. The acquisition
CODEGO Celebrates 350,000+ Active Users By Showcasing Latest Product in Bid to Revolutionize the Finance Space
CODEGO Celebrates 350,000+ Active Users By Showcasing Latest Product in Bid to R …
CODEGO is a white-label electronic money and card-issuing service based in Europe. Image: https://www.globalnewslines.com/uploads/2025/09/a9150d1bbecba26b3b420152ca06e818.jpg CODEGO [https://codegopay.com], the Europe-based white-label electronic money and card-issuing service, has officially crossed 350,000 satisfied users, marking the occasion with a showcase of their latest products and offerings. The latest expansion sees the team making additions to their comprehensive white-label Banking-as-a-Service (BaaS) platform. Drawing on 12 years of combined expertise in programming, finance, and authentication systems, CODEGO empowers clients to

All 5 Releases


More Releases for GenoFAB

Bio-Based Molecule Market Driven by Sustainability Goals and Rising Demand for B …
"The Global Bio-based Molecule Market reached US$1,336.72 million in 2023 and is expected to reach US$2,437.83 million by 2031, growing with a CAGR of 7.8% during the forecast period 2024-2031," according to DataM Intelligence. The Bio-Based Molecule Market is spearheaded by leading industrial biotech firms, including Arkema, Covestro, and Borregaard, backed by global engineering groups like GEA Group and DE Smet Engineers. AVA Biochem, Jiangmen Xinshuo, and NTIC excel in fine
04-16-2025 | Health & Medicine
Getnews
GenoFAB Joins BioMADE to Accelerate Industrial Biomanufacturing Through Advanced …
Colorado State University startup GenoFAB has joined BioMADE, connecting with over 300 organizations nationwide to advance biomanufacturing innovation. GenoFAB contributes critical expertise in genetic design and plasmid management, helping engineer microorganisms that transform raw materials into sustainable products. This partnership strengthens America's bioindustrial manufacturing capabilities while accelerating research and product development in the bioeconomy. Image: https://www.globalnewslines.com/uploads/2025/04/c446c077297e9ab30d36c42f32bd9d44.jpg Fort Collins, CO - GenoFAB [https://genofab.com/], a Colorado State University startup [https://csustrata.org/technology-transfer/startups/meet-our-startups/], has joined BioMADE, a
North America Bioinformatics Market Will Accelerate Rapidly with Promising CAGR …
The North America Bioinformatics market is estimated to grow at a high CAGR from 2024 to 2031. The North America North America Bioinformatics Market report is the most important research for who looks for all information about the market. The report covers all information about the regional markets, including historical and future trends for market dominance, size, trades, supply, competitors, and prices, as well as key vendor information across the region.
NA Bioinformatics Market Size, Share, Industry, Forecast to 2029
The NA Bioinformatics Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global NA Bioinformatics market. This report explores all the key factors affecting the growth of the global NA Bioinformatics market, including
APAC Bioinformatics Market Size, Share, Industry, Forecast to 2029
The APAC Bioinformatics Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global APAC Bioinformatics market. This report explores all the key factors affecting the growth of the global APAC Bioinformatics market, including
MEA Bioinformatics Market Size, Share, Industry, Forecast to 2029
The MEA Bioinformatics Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global MEA Bioinformatics market. This report explores all the key factors affecting the growth of the global MEA Bioinformatics market, including